Fourth Dimension Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Fourth Dimension Wealth's BMY Position: Q2 2026 in Review
Fourth Dimension Wealth increased its Bristol-Myers Squibb (BMY) stake by 29% in Q2 2026, buying an estimated $4.19K and bringing the position to 323 shares worth $18.6K. The position accounts for 0.01% of the portfolio, ranked #393.
Fourth Dimension Wealth first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $47.9K in Q4 2024. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Fourth Dimension Wealth held 323 shares of Bristol-Myers Squibb worth $18.6K as of Q2 2026.
- Fourth Dimension Wealth bought 73 Bristol-Myers Squibb shares in Q2 2026, an estimated $4.19K.
- Bristol-Myers Squibb made up 0.01% of Fourth Dimension Wealth's portfolio in Q2 2026, its #393 holding.
- Fourth Dimension Wealth first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
- Fourth Dimension Wealth's Bristol-Myers Squibb position peaked at $47.9K in Q4 2024.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Fourth Dimension Wealth's 13F filing for Q2 2026, filed 31 Jul 2026.